Sana Biotechnology, Inc. (SANA)
3.13
+0.04
(+1.29%)
USD |
NASDAQ |
Sep 11, 16:00
3.12
-0.01
(-0.32%)
After-Hours: 05:50
Sana Biotechnology Price to Book Value : 6.061 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.061 |
| September 10, 2026 | 5.984 |
| September 09, 2026 | 6.138 |
| September 08, 2026 | 6.681 |
| September 04, 2026 | 7.455 |
| September 03, 2026 | 7.591 |
| September 02, 2026 | 7.533 |
| September 01, 2026 | 7.416 |
| August 31, 2026 | 7.494 |
| August 28, 2026 | 7.610 |
| August 27, 2026 | 7.920 |
| August 26, 2026 | 8.056 |
| August 25, 2026 | 7.939 |
| August 24, 2026 | 7.320 |
| August 21, 2026 | 7.571 |
| August 20, 2026 | 7.242 |
| August 19, 2026 | 7.939 |
| August 18, 2026 | 7.029 |
| August 17, 2026 | 7.126 |
| August 14, 2026 | 6.874 |
| August 13, 2026 | 7.107 |
| August 12, 2026 | 7.300 |
| August 11, 2026 | 7.339 |
| August 10, 2026 | 6.990 |
| August 07, 2026 | 6.816 |
| Date | Value |
|---|---|
| August 06, 2026 | 6.603 |
| August 05, 2026 | 6.797 |
| August 04, 2026 | 6.584 |
| August 03, 2026 | 6.158 |
| July 31, 2026 | 6.061 |
| July 30, 2026 | 6.293 |
| July 29, 2026 | 6.138 |
| July 28, 2026 | 6.371 |
| July 27, 2026 | 6.351 |
| July 24, 2026 | 6.158 |
| July 23, 2026 | 6.216 |
| July 22, 2026 | 6.042 |
| July 21, 2026 | 6.119 |
| July 20, 2026 | 6.080 |
| July 17, 2026 | 6.100 |
| July 16, 2026 | 6.138 |
| July 15, 2026 | 6.874 |
| July 14, 2026 | 6.913 |
| July 13, 2026 | 7.048 |
| July 10, 2026 | 7.455 |
| July 09, 2026 | 7.610 |
| July 08, 2026 | 7.707 |
| July 07, 2026 | 7.978 |
| July 06, 2026 | 7.688 |
| July 02, 2026 | 7.765 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.259 |
| Twist Bioscience Corp. | 17.89 |
| Beam Therapeutics, Inc. | 2.321 |
| Prime Medicine, Inc. | 14.21 |
| Moderna, Inc. | 8.496 |
Price to Book Value Related Metrics
| Price | 3.13 |
| Earnings Yield | -24.30% |
| Market Cap | 936.83M |